Latest Breaking News On - Pfizer oncology research development group - Page 1 : comparemela.com
Pfizer to Acquire Trillium Therapeutics Inc
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Pfizer To Buy Trillium Therapeutics For $18 50/Shr Cash
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Pfizer to Acquire Trillium Therapeutics Inc
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
Pfizer to Acquire Trillium Therapeutics Inc
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Pfizer pours $25m into Vedanta s Phase II IBD study The pharma giant has invested in the clinical trial exploring the viability of Vedanta Biosciences’ VE202 inflammatory bowel disease treatment candidate.
PureTech Health, a clinical-stage biotherapeutics firm, has announced its Vedanta Biosciences founded entity has landed a $25m (20.6 EUR) investment as part of the Pfizer Breakthrough Growth Initiative (PGBI). Vedanta plans to use the money to fund its Phase II study of VE202 to treat inflammatory bowel disease (IBD), scheduled to launch in 2021.
A Vedanta spokesperson told Outsourcing-Pharma that, “
We see this investment as valuable external validation of Vedanta’s approach to microbiome drug development, which we hope this will be the beginning of a fruitful partnership between Vedanta and Pfizer. The investment enables us to move aggressively with Phase II plans.”